Effect of the saliva biomolecules on the interface zirconia/Ti6Al4V triboactivity

por Teixeira, H., Serro, A.P, Figueiredo-Pina, C. G.
Publicado 2021

HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo‐controlled...

por Kimball, A.B., Sobell, J.M., Zouboulis, C.C., Gu, Y., Williams, D.A., Sundaram, M., Teixeira, H.D., Jemec, G.B.E.
Publicado 2015

Assessing Noncoding Sequence Variants of GJB2 for Hearing Loss Association

por Matos, T. D., Simões-Teixeira, H., Caria, H., Cascão, R., Rosa, H., O'Neill, A., Dias, Ó., Andrea, M. E., Kelsell, D. P., Fialho, G.
Publicado 2011

Adalimumab medium‐term dosing strategy in moderate‐to‐severe hidradenitis suppurativa: integrated results from the phase III randomized placebo‐controlled PIONEER trials

por Jemec, G.B.E., Okun, M.M., Forman, S.B., Gulliver, W.P.F., Prens, E.P., Mrowietz, U., Armstrong, A.W., Geng, Z., Gu, Y., Williams, D.A., Teixeira, H.D., Kimball, A.B.
Publicado 2019

Efficacy and safety of adalimumab in Chinese patients with moderate‐to‐severe plaque psoriasis: results from a phase 3, randomized, placebo‐controlled, double‐blind study

por Cai, L., Gu, J., Zheng, J., Zheng, M., Wang, G., Xi, L.‐Y., Hao, F., Liu, X.‐M., Sun, Q.‐N., Wang, Y., Lai, W., Fang, H., Tu, Y.‐T., Sun, Q., Chen, J., Gao, X.‐H., Gu, Y., Teixeira, H.D., Zhang, J.‐Z., Okun, M.M.
Publicado 2016